An eye toward the clinic, Israel’s Compugen works to transform itself admin June 8, 2017 Blog Read more: https://www.bioworld.com/report/BWT053017Compugen.pdf You Might Also Like Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board February 28, 2017 In global first, Teva signs deal to market medical marijuana inhaler December 6, 2016 Physicists take first step toward cell-sized robots February 25, 2018
Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board February 28, 2017
